Skip to main content
Fig. 1 | BMC Pulmonary Medicine

Fig. 1

From: Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites

Fig. 1

The diversity and richness of the gut microbiota in lung cancer patients (C) and benign diseases patients (N). (A) α-diversity between C and N groups based on the ace, chao, shannon, sobs, coverage and simpson indexes. (B) Non-metric multidimensional scaling (NMDS) analysis of C and N. (C) Partial Least Squares Discriminant Analysis (PLS-DA) of C and N

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us